H. J. Gjessing

435 total citations
22 papers, 332 citations indexed

About

H. J. Gjessing is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, H. J. Gjessing has authored 22 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Genetics and 8 papers in Surgery. Recurrent topics in H. J. Gjessing's work include Diabetes and associated disorders (14 papers), Diabetes Management and Research (12 papers) and Pancreatic function and diabetes (7 papers). H. J. Gjessing is often cited by papers focused on Diabetes and associated disorders (14 papers), Diabetes Management and Research (12 papers) and Pancreatic function and diabetes (7 papers). H. J. Gjessing collaborates with scholars based in Denmark, Cyprus and United States. H. J. Gjessing's co-authors include O. K. Faber, Louise Hauge Matzen, Anders Frøland, Else Marie Skjøde Damsgaard, E. Vestbo, Ellen Grodum, Bent Ejlertsen, Søren H. Sindrup, Claus Hagen and Kirsten Nørgaard and has published in prestigious journals such as Diabetes Care, Diabetes and Diabetologia.

In The Last Decade

H. J. Gjessing

21 papers receiving 311 citations

Peers

H. J. Gjessing
G. Rayman United Kingdom
Nino G. Joy United States
J.E. Schopman Netherlands
Henry K. Driscoll United States
R. D. G. Leslie United Kingdom
R F James United Kingdom
Smita Baid United States
G. Rayman United Kingdom
H. J. Gjessing
Citations per year, relative to H. J. Gjessing H. J. Gjessing (= 1×) peers G. Rayman

Countries citing papers authored by H. J. Gjessing

Since Specialization
Citations

This map shows the geographic impact of H. J. Gjessing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. J. Gjessing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. J. Gjessing more than expected).

Fields of papers citing papers by H. J. Gjessing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. J. Gjessing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. J. Gjessing. The network helps show where H. J. Gjessing may publish in the future.

Co-authorship network of co-authors of H. J. Gjessing

This figure shows the co-authorship network connecting the top 25 collaborators of H. J. Gjessing. A scholar is included among the top collaborators of H. J. Gjessing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. J. Gjessing. H. J. Gjessing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nørgaard, Kirsten, John Shin, John Welsh, & H. J. Gjessing. (2015). Performance and Acceptability of a Combined Device for Insulin Infusion and Glucose Sensing in the Home Setting. Journal of Diabetes Science and Technology. 9(2). 215–220. 16 indexed citations
2.
Marmolin, Ea Sofie, et al.. (2012). Better treatment of outpatients with type 1 diabetes after introduction of continuous subcutaneous insulin infusion.. PubMed. 59(6). A4445–A4445. 5 indexed citations
3.
Gram, Jeppe, Jan Erik Henriksen, Ellen Grodum, et al.. (2010). Pharmacological Treatment of the Pathogenetic Defects in Type 2 Diabetes. Diabetes Care. 34(1). 27–33. 28 indexed citations
4.
Vestbo, E., Anders Frøland, J. Ingerslev, et al.. (2002). Insulin resistance is accompanied by increased von Willebrand factor levels in nondiabetic women: a study of offspring of type 2 diabetic subjects compared to offspring of nondiabetic subjects. Journal of Internal Medicine. 252(2). 155–163. 6 indexed citations
6.
Eyben, Finn Edler von, et al.. (1994). Metabolic remission with octreotide in patients with insulinoma. Journal of Internal Medicine. 235(3). 245–248. 19 indexed citations
7.
Gjessing, H. J., et al.. (1992). The Effect of Chronic Hyperglycaemia on the Islet B‐cell Responsiveness in Newly Diagnosed Type 2 Diabetes. Diabetic Medicine. 9(7). 601–604. 10 indexed citations
8.
Gjessing, H. J., et al.. (1991). The effect of acute hyperglycemia on the plasma C-peptide response to intravenous glucagon or to a mixed meal in insulin-dependent diabetes mellitus. European Journal of Endocrinology. 124(5). 556–562. 15 indexed citations
9.
Matzen, Louise Hauge, et al.. (1990). Different short-term effect of protein and carbohydrate intake on TSH, growth hormone (GH), insulin, C-peptide, and glucagon in humans. Scandinavian Journal of Clinical and Laboratory Investigation. 50(7). 801–805. 4 indexed citations
10.
Gjessing, H. J.. (1990). [C-peptide measurement in the classification of diabetes mellitus and in the assessment of requirements for insulin treatment].. PubMed. 152(9). 588–93. 1 indexed citations
11.
Matzen, Louise Hauge, et al.. (1990). Different short-term effect of protein and carbohydrate intake on TSH, growth hormone (GH), insulin, C-peptide, and glucagon in humans. Scandinavian Journal of Clinical and Laboratory Investigation. 50(7). 801–805. 1 indexed citations
12.
Sindrup, Søren H., Bent Ejlertsen, H. J. Gjessing, Anders Jørgen Svendsen, & Anders Frøland. (1989). Peripheral nerve function during hyperglycemic clamping in insulin-dependent diabetic patients. Acta Neurologica Scandinavica. 79(5). 412–418. 13 indexed citations
13.
Gjessing, H. J., et al.. (1989). Sensitivity and Reproducibility of Urinary C‐peptide as Estimate of Islet B‐cell Function in Insulin‐treated Diabetes. Diabetic Medicine. 6(4). 329–333. 11 indexed citations
15.
Gjessing, H. J., et al.. (1989). Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes. Diabetologia. 32(5). 305–311. 74 indexed citations
17.
Gjessing, H. J., Else Marie Skjøde Damsgaard, Louise Hauge Matzen, O. K. Faber, & Anders Frøland. (1988). The beta-cell response to glucagon and mixed meal stimulation in non-insulin dependent diabetes. Scandinavian Journal of Clinical and Laboratory Investigation. 48(8). 771–777. 4 indexed citations
18.
Sindrup, Søren H., Bent Ejlertsen, H. J. Gjessing, Anders Frøland, & E Sindrup. (1988). Peripheral nerve function during hyperglycemic clamping in healthy subjects. Acta Neurologica Scandinavica. 78(2). 141–145. 10 indexed citations
19.
Gjessing, H. J., Else Marie Skjøde Damsgaard, Louise Hauge Matzen, Anders Frøland, & O. K. Faber. (1987). Reproducibility of βCell Function Estimates in Non-Insulin-Dependent Diabetes Mellitus. Diabetes Care. 10(5). 558–562. 19 indexed citations
20.
Gjessing, H. J., Louise Hauge Matzen, Anders Frøland, & O. K. Faber. (1987). Correlations Between Fasting Plasma C-Peptide, Glucagon-Stimulated Plasma C-Peptide, and Urinary C-Peptide in Insulin-Treated Diabetics. Diabetes Care. 10(4). 487–490. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026